<?xml version="1.0" encoding="UTF-8"?>
<ref id="B101-jcm-09-01407">
 <label>101.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>Canadian Cardiovascular Society</collab>
  </person-group>
  <article-title>COVID-19 and Concerns Regarding Use of ACEi/ARB/ARNi Medications for Heart Failure or Hypertension</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="http://www.ccs.ca/images/Images_2020/CCS_CHFS_statement_regarding_COVID_EN.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.ccs.ca/images/Images_2020/CCS_CHFS_statement_regarding_COVID_EN.pdf</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-04-25">(accessed on 25 April 2020)</date-in-citation>
 </element-citation>
</ref>
